x

Rallybio Corp (Nasdaq:RLYB)

Health Care/Life Sciences • Pharmaceuticals
CIK 1739410
Company

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.

Address
234 Church Street
Suite 1020
New Haven, Connecticut 06510
Employees
43
Stock Info
Close
$0.6960
Day Range
0.6905 - 0.7316
52 Week Range
0.6800 - 3.4600
Average volume
82.36K
Short Interest
331.09K (02/14/25)
% of Float Shorted
1.62%
Market Cap
$28.88M
Revenue
N/A
Net Income
-$74.56M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.5898
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Martin W. MacKay
President, Chief Executive Officer & Director
Stephen Uden
Director
Christine A. Nash
Director
Liu Hui
Director
Wendy K. Chung
Independent Director
Ronald M. Hunt
Independent Director
Helen Marie Boudreau
Independent Director
Robert L. Hopfner
Independent Director
Lucian Iancovici
Lead Independent Director
Paula Soteropoulos
SEC filings
DateFormEvent
12 Nov, 2024 SC 13G/A
7 Nov, 2024 10-Q
7 Nov, 2024 8-K
17 Sep, 2024 8-K
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
30 Jul, 2024 SC 13G
30 Jul, 2024 SC 13G/A
23 Jul, 2024 8-K
21 May, 2024 8-K
20 May, 2024 EFFECT
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
17 May, 2024 4
16 May, 2024 CORRESP
16 May, 2024 UPLOAD
10 May, 2024 S-3
9 May, 2024 10-Q
9 May, 2024 8-K
22 Apr, 2024 D
11 Apr, 2024 DEF 14A
10 Apr, 2024 8-K
13 Mar, 2024 S-8
12 Mar, 2024 10-K
12 Mar, 2024 8-K
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
14 Feb, 2024 SC 13G/A
12 Feb, 2024 SC 13D/A
9 Feb, 2024 SC 13G/A
6 Feb, 2024 8-K
4 Jan, 2024 4
4 Jan, 2024 4
2 Jan, 2024 SC 13G/A
20 Dec, 2023 8-K
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
8 Aug, 2023 10-Q
8 Aug, 2023 8-K
29 Jun, 2023 8-K CEO Change
22 May, 2023 8-K
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
12 May, 2023 EFFECT
12 May, 2023 424B3
11 May, 2023 CORRESP
11 May, 2023 UPLOAD
10 May, 2023 S-8
9 May, 2023 10-Q
9 May, 2023 S-3
9 May, 2023 8-K
10 Apr, 2023 DEF 14A
16 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
6 Mar, 2023 8-K
6 Mar, 2023 10-K
9 Feb, 2023 SC 13G/A
6 Feb, 2023 4
6 Feb, 2023 SC 13G/A
6 Feb, 2023 4
6 Feb, 2023 4
1 Feb, 2023 4
1 Feb, 2023 3
1 Feb, 2023 SC 13G/A
31 Jan, 2023 8-K
23 Jan, 2023 SC 13G/A
5 Jan, 2023 4
5 Jan, 2023 4
5 Jan, 2023 4
5 Jan, 2023 4
1 Dec, 2022 8-K
17 Nov, 2022 SC 13G
17 Nov, 2022 4
14 Nov, 2022 8-K
14 Nov, 2022 424B5
10 Nov, 2022 424B5
7 Nov, 2022 10-Q
7 Nov, 2022 8-K
28 Sep, 2022 8-K
15 Aug, 2022 EFFECT
15 Aug, 2022 424B5
11 Aug, 2022 UPLOAD
11 Aug, 2022 CORRESP
8 Aug, 2022 S-3
8 Aug, 2022 10-Q
8 Aug, 2022 8-K
3 Aug, 2022 4
3 Aug, 2022 3
2 Aug, 2022 8-K
7 Jun, 2022 4
7 Jun, 2022 4
7 Jun, 2022 SC 13D/A
6 Jun, 2022 S-8
2 Jun, 2022 8-K
27 May, 2022 8-K
26 May, 2022 4
26 May, 2022 4
26 May, 2022 4
26 May, 2022 4
26 May, 2022 4
26 May, 2022 4
26 May, 2022 4
25 May, 2022 4
25 May, 2022 4
10 May, 2022 8-K
10 May, 2022 10-Q
25 Apr, 2022 DEF 14A
6 Apr, 2022 4
6 Apr, 2022 3
6 Apr, 2022 3
6 Apr, 2022 4
4 Apr, 2022 8-K
23 Mar, 2022 4
15 Mar, 2022 8-K
15 Mar, 2022 10-K
7 Mar, 2022 8-K
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G
10 Feb, 2022 4
10 Feb, 2022 4
9 Feb, 2022 4
9 Feb, 2022 4
9 Feb, 2022 4
9 Feb, 2022 4
8 Feb, 2022 SC 13G
21 Jan, 2022 SC 13G
21 Jan, 2022 4
18 Jan, 2022 SC 13D/A
14 Jan, 2022 4
12 Jan, 2022 4
11 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
10 Nov, 2021 8-K
10 Nov, 2021 10-Q
9 Sep, 2021 8-K
9 Sep, 2021 10-Q
12 Aug, 2021 SC 13D
12 Aug, 2021 SC 13D
12 Aug, 2021 SC 13D
9 Aug, 2021 SC 13G
4 Aug, 2021 4
4 Aug, 2021 4
4 Aug, 2021 4
4 Aug, 2021 4
4 Aug, 2021 4
4 Aug, 2021 4
4 Aug, 2021 3/A
4 Aug, 2021 SC 13G
2 Aug, 2021 S-8
2 Aug, 2021 8-K
2 Aug, 2021 4
30 Jul, 2021 424B4 IPO completed
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 3
29 Jul, 2021 CERT
29 Jul, 2021 8-A12B
28 Jul, 2021 EFFECT
28 Jul, 2021 SEC STAFF
28 Jul, 2021 S-1MEF
26 Jul, 2021 CORRESP
26 Jul, 2021 CORRESP
22 Jul, 2021 S-1/A
12 Jul, 2021 CORRESP
2 Jul, 2021 S-1
7 Jun, 2021 DRS/A
7 Jun, 2021 DRSLTR
24 May, 2021 UPLOAD
13 May, 2021 SEC STAFF
27 Apr, 2021 DRS
Last update:2025-03-06 13:15:26.987751

Sign Up to Subscribe